Terug

Watch Compare

Q32 Bio Inc.

Datakwaliteit: 100%

QTTB

Nasdaq Manufacturing Chemicals

€ 4,95

▼ € 0,52 (-9,51%)

Marktkapitalisatie: 72,42 M

Prijs

€ 4,95

Marktkapitalisatie

72,42 M

Dagbereik

€ 4,83 — € 5,50

52-Weeksbereik

€ 1,35 — € 8,05

Volume

301.155

Openen € 5,39

50D / 200D Gem.

€ 5,14

3,79% below

50D / 200D Gem.

€ 3,12

58,63% above

Quick Summary

Belangrijkste Punten

Revenue grew 12,15% annually over 5 years — strong growth

Net margin of 55,49% shows strong profitability

Negative free cash flow of -33,54 M

P/E of 2,43 — trading at a low valuation

Capital efficient — spends only 0,00% of revenue on capex

ROIC of 33,38% — excellent capital efficiency

Groei

Revenue Growth (5Y)

12,15%

Boven sectorgemiddelde (1,82%)

Revenue (1Y)N/A

Earnings (1Y)N/A

FCF Growth (3Y)N/A

Kwaliteit

Return on Equity

N/A

ROIC33,38%

Net Margin55,49%

Op. Margin31,45%

Veiligheid

Debt / Equity

N/A

Current Ratio4,57

Interest Coverage16,02

Waardering

PE (TTM)

2,43

Boven sectorgemiddelde (-1,48)

P/B RatioN/A

EV/EBITDA1,38

Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)

Metriek	Aandeel	Sector Mediaan
P/E	2,4	-1,5
P/B	—	1,6
ROE %	—	-53,4
Net Margin %	55,5	-41,5
Rev Growth 5Y %	12,2	1,8
D/E	—	0,3

All Fundamental Metrics

Growth
Revenue Growth (1Y)	N/A	Revenue Growth (3Y)	581,80%
Earnings Growth (1Y)	N/A	Earnings Growth (3Y)	N/A
Revenue Growth (5Y)	12,15%	Earnings Growth (5Y)	N/A
Profitability
Revenue (TTM)	53,74 M	Net Income (TTM)	29,82 M
ROE	N/A	ROA	48,14%
Gross Margin	N/A	Operating Margin	31,45%
Net Margin	55,49%	Free Cash Flow (TTM)	-33,54 M
ROIC	33,38%	FCF Growth (3Y)	N/A
Safety
Debt / Equity	N/A	Current Ratio	4,57
Interest Coverage	16,02	Asset Turnover	0,87
Working Capital	39,70 M	Tangible Book Value	-18,45 M
Dividends
Dividend Yield	N/A	Payout Ratio	N/A
Dividend Growth (3Y)	N/A	Dividend Growth (5Y)	N/A
Consecutive Div Years	N/A
Valuation
P/E Ratio	2,43	Forward P/E	N/A
P/B Ratio	N/A	P/S Ratio	1,35
PEG Ratio	N/A	Forward PEG	N/A
EV/EBITDA	1,38	Fwd EV/EBITDA	N/A
Forward P/S	N/A	Fwd Earnings Yield	N/A
FCF Yield	-46,32%
Market Cap	72,42 M	Enterprise Value	23,38 M
Per Share
EPS (Diluted TTM)	2,42	Revenue / Share	3,67
FCF / Share	-2,29	OCF / Share	-2,29
EPS CAGR (1Y)	N/A	EPS CAGR (5Y)	N/A
EPS CAGR (10Y)	N/A
Efficiency
CapEx / Revenue	0,00%	FCF Conversion	-112,48%
SBC-Adj. FCF	-38,71 M	Growth Momentum	N/A

Income Statement

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	53,74 M	0,0	1,16 M	3,21 M	33,97 M
Net Income	29,82 M	-47,73 M	-112,96 M	-5,01 M	-95,76 M
EPS (Diluted)	2,42	-6,58	-1,95	-0,09	—
Gross Profit	—	—	—	—	—
Operating Income	16,90 M	-66,10 M	-101,43 M	-133,28 M	-95,95 M
EBITDA	—	—	—	—	—
R&D Expenses	19,16 M	48,14 M	62,00 M	98,35 M	93,09 M
SG&A Expenses	—	—	—	—	—
D&A	—	—	—	—	—
Interest Expense	1,06 M	1,50 M	—	—	—
Income Tax	0,0	21.000,0	0,0	715.000,0	0,0

Balance Sheet

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Total Assets	61,78 M	92,33 M	84,56 M	228,47 M	211,72 M
Total Liabilities	19,76 M	86,66 M	11,57 M	50,49 M	42,07 M
Shareholders' Equity	42,01 M	5,68 M	72,99 M	177,98 M	169,65 M
Total Debt	—	—	—	—	—
Cash & Equivalents	48,30 M	77,97 M	39,27 M	33,99 M	108,38 M
Current Assets	55,05 M	81,88 M	83,91 M	181,02 M	191,91 M
Current Liabilities	11,35 M	16,47 M	11,57 M	22,58 M	17,23 M